A new approach to treatment of no-reflow following percutaneous coronary intervention using self-mad

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户:slksm
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background An optimal standard treatment for no reflow (NR) has not yet been established.Intracoronary administration of drug via guiding catheter or micro-catheter is major treatment method of no-reflow.We sought to evaluate the feasibility of using self-made side hole balloon treating no-reflow following percutaneous coronary intervention (PCI).
其他文献
Background Transcatheter valve interventions (TAVI) and innovative coronary surgery (endoscopic) procedures require angiographic intraoperative imaging supporting an interdisciplinary therapeutic appr
会议
Background Catheter-based renal sympathetic denervation (RDN) was introduced as a novel interventional technique in recent years,which could simultaneously block the renal artery afferent and efferent
会议
Background Catheter-based renal sympathetic denervation (RDN) was introduced as a novel interventional technique in recent years,which could simultaneously block the renal artery afferent and efferent
会议
Background We hope to provide a management of patients with severe fulminant myocarditis,by analysis of a patient of severe fulminant myocarditis with pump failure,shock,and arrhythmia using extracorp
会议
Background Transcatheter LAA occlusion is an alternative and effective approach to long-term anticoagulation therapy in patients with nonvalvular atrial fibrillation.The study was designed to compare
会议
Background This study was to investigate the clinical effect of evidence-based nursing on permanent pacemaker implantation treatment in perioperative period.Methods A total of 126 patients on permanen
会议
Background Coronary artery intervention diagnosis and treatment technology via radial artery approach has been successfully used for clinical purposes,for the minimally invasive treatment,rapid recove
会议
Background Percutaneous coronary stent implantation has advantages of less trauma,quicker recovery and significant effect.The development of this technology is quite mature.However,a majority of patie
会议
Background Congenital heart disease (CHD) is the most common pediatric heart disease.The detection rate is 0.7% in the newborn.We estimate that there are up to 150-170 thousands new born children with
会议
Background This study is to evaluate the effects and security of single septal branch blood vessel and no single one by PTSMA in patients with HOCM.Methods Patients with symptomatic drug-refractory HO
会议